This week we have welcomed Abraham Choong to the Quantify Research team!
Abraham has held progressively senior positions at industry-leading organizations and brings a wealth of experience in account management and business development in the […]
The Quantify Research team are back and ready to get into in the swing of things following our Christmas break.
With fresh New Years Resolutions at the ready we look forward to catching up with […]
Since 2020, Quantify Research has been a proud partner to the European Medicines Agency-coordinated ENCePP (European Network for Centers of Pharmacoepidemiology and Pharmacovigilance) initiative.
This network brings together expertise […]
𝐌𝐀𝐒𝐋𝐃/𝐌𝐀𝐒𝐇: 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐚𝐧𝐝 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐟𝐫𝐨𝐦 40-𝐲𝐞𝐚𝐫 𝐅𝐨𝐥𝐥𝐨𝐰-𝐔𝐩 𝐃𝐚𝐭𝐚
On Tuesday December 10th, Quantify’s Emilie Toresson Grip is one of three speakers at ISPOR’s webinar on MASLD/ MASH following their BRIDGE-MASH study.
Moderated by Riku Ota, Global Payer Evidence Lead at […]
How does Quantify Research as a consultant research organisation compare to academia when it comes to generating RWE?
Here’s a quick look at the unique strengths of each – and why both are vital for […]
As the number one provider of Nordic registry studies, Quantify sits at the heart of Scandinavia.
The Nordics typically refers to Northern European countries with similar history, culture and social structures.
They include Denmark, […]
The Quantify Research team is back from the ISPOR—The Professional Society for Health Economics and Outcomes Research congress and feeling excited – the conference was a huge success.
Our […]
Last week our colleague Nicholas Norton returned from spending some time with the Quantify Research team in Chandigarh. Over the course of two weeks Nicholas managed to squeeze in work, great team building and […]
Last week, Quantify’s Emilie Toresson Grip was invited to the first Swedish Steatotic Liver Disease (SLD) Think Tank, hosted by Karolinska Institutet.
24 hours packed with speed networking, group discussions, and insightful presentations.
The primary goals? […]
The use of Real-World Data (RWD) to support regulatory decisions is growing rapidly.
Several regulating agencies have in the past few years issued guidelines on the requirements on Real-World Evidence (RWE)-studies to be fit-for purpose for regulatory purposes.
Nordic data properties share […]